ONCOLYTICS BIOTECH INC's ticker is ONCYF and the CUSIP is 682310107. A total of 33 filers reported holding ONCOLYTICS BIOTECH INC in Q4 2014. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2015 | $16,000 | -83.8% | 36,199 | -81.8% | 0.00% | -100.0% |
| Q2 2015 | $99,000 | +725.0% | 198,811 | +1092.2% | 0.00% | – |
| Q1 2015 | $12,000 | -86.0% | 16,676 | -89.7% | 0.00% | -100.0% |
| Q4 2014 | $86,000 | +352.6% | 161,357 | +385.6% | 0.00% | – |
| Q3 2014 | $19,000 | -47.2% | 33,227 | +65.9% | 0.00% | – |
| Q1 2014 | $36,000 | -14.3% | 20,025 | -25.5% | 0.00% | – |
| Q4 2013 | $42,000 | +31.2% | 26,872 | +102.6% | 0.00% | – |
| Q3 2013 | $32,000 | – | 13,261 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NEXT Financial Group, Inc | 43,000 | $19,000 | 0.01% |
| VSR Financial Services, Inc. | 119,630 | $54,000 | 0.01% |
| TCI Wealth Advisors, Inc. | 1,200 | $1,000 | 0.00% |
| BANK OF AMERICA CORP /DE/ | 11,944 | $5,000 | 0.00% |
| STIFEL FINANCIAL CORP | 24,500 | $11,000 | 0.00% |
| FIRST MANHATTAN CO. LLC. | 1,000 | $0 | 0.00% |
| WELLS FARGO & COMPANY/MN | 1,000 | $0 | 0.00% |
| GROUP ONE TRADING, L.P. | 38,529 | $18,000 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 44,017 | $20,000 | 0.00% |
| HOWE & RUSLING INC | 1,017 | $0 | 0.00% |